Aegis Analytical Corp.

Pharmaceutical IT company closes $3.5M equity funding and announces new appointment

Published in Lab Business Week, January 1st, 2006

Aegis Analytical Corp., a provider of software solutions and services for pharmaceutical and biotechnology manufacturers, announced the close of $3.5 million in equity financing and the appointment of Robert D. Gills, Jr., as vice president of business development.

The investment round was led by Boulder, Colorado-based Skyland Capital, which was joined by four previous investors - Future Capital AG (Frankfurt, Germany), Lafayette Equity Fund, LP, Merck Capital Ventures, LLC, a subsidiary of Merck & Co., Inc., and 3i, a leading international venture capital company. Aegis has received more than $25 million in funding to date.

"With new capital and an...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Lab Business Week

Source: Lab Business Week (2006-01-01)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry